Trademark Overview
On Wednesday, November 6, 2024, a trademark application was filed for NUVIE BIO with the United States Patent and Trademark Office. The USPTO has given the NUVIE BIO trademark a serial number of 98840584. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, November 6, 2024. This trademark is owned by NUVIE BIO, Inc.. The NUVIE BIO trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations and substances for the treatment of migraine, headache, menstrual migraine, dysmenorrhea, endometriosis, fibromyalgia, irritable bowel syndrome, cluster headache, and post-traumatic headache; pharmaceutical preparations and substances for the acute and preventive treatment of migraine, headache, menstrual migraine, dysmenorrhea, endometriosis, fibromyalgia, irritable bowel syndrome, cluster headache, and post-traumatic headache; pharmaceutical preparations and substances for the treatment of neurological diseases and disorders; migraine and headache treatment preparations; migraine and headache prevention preparations
Medical information services in the field of treatment of migraine, headache, menstrual migraine, dysmenorrhea, endometriosis, fibromyalgia, irritable bowel syndrome, cluster headache, and post-traumatic headache; medical information services in the field of treatment of neurological diseases and disorders
Pharmaceutical research and development for the treatment of migraine, headache, menstrual migraine, dysmenorrhea, endometriosis, fibromyalgia, irritable bowel syndrome, cluster headache, and post-traumatic headache; pharmaceutical research and development for the acute and preventive treatment of migraine, headache, menstrual migraine, dysmenorrhea, endometriosis, fibromyalgia, irritable bowel syndrome, cluster headache, and post-traumatic headache; pharmaceutical research and development for the treatment of neurological diseases and disorders